Table 1 Final ratings for outcome domains in studies of acute gout
Median rating (30th to 70th percentiles)‡Disagreement index§
Pain*1 (1 to 1)0
Patient global*2 (1 to 2)0.22
Physician global2 (2 to 3)0.32
Work disability (absentee-ism or presentee-ism)3 (2 to 3)0.32
Inflammation of joint*†
    Joint erythema3 (2 to 3)0.32
    Joint tenderness1 (1 to 2)0.22
    Joint swelling1 (1 to 2)0.22
    Acute phase marker3 (2 to 4)0.85
Function*†
    Functional disability (difficulty with daily activities)2 (1 to 3)0.52
    Joint impairment (loss of joint motion)3 (2 to 4)0.85
  • *Items recommended by OMERACT SIG.

  • †These two items were rated highly in the first iteration (median 1) but respondents requested more precise clarification of meaning for subsequent iterations.

  • ‡Ratings of 1–3 indicate item should be included in studies of gout; 4 indicates uncertainty; 5–7 indicate item should not be included in studies of gout.

  • §A disagreement index of less than 1 indicates no disagreement.10